Keyword [design synthesis] Result: 181 - 200 | Page: 10 of 10 |
181. | Design,Synthesis And Cerebrocardiac Vascular Pharmacological Activity Studies Of The Novel Ligustrazine Derivatives |
182. | Design, Synthesis And Biological Evaluation Of Silybin Analogues |
183. | Design, Synthesis And Antitumor Activities Study Of Nitrogen-containing Flavonoids |
184. | Design, Synthesis And Structure-Activity Relationships Study Of Flavonoids As AChE Inhibitors |
185. | Design, Synthesis And Determination Of Peroxidase Peptide Mimetics |
186. | Design, Synthesis And Biological Activity Of Novel Caspase Inhibitors |
187. | Design, Synthesis And Biological Activity Of Novel Caspase Inhibitors |
188. | Design, Synthesis And Expression Of SMAP-29 Gene And Assay The Antibacterial Activity Of SMAP-29 |
189. | Design, Synthesis And Application Exploration Of Hydroxyl Porphyrins And Chiral Liquid Crystal |
190. | Studies On Design,Synthesis And Activity Of Hydroxamate Acids Derivatives As Histone Deacetylases Inhibitors |
191. | HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis And Antiviral Evaluation Of Novel 1,3-Disubstituted Thieno[3,2-e][2,1,3] Thiadiazin-4-one 2,2-Dioxides (TTDDs) |
192. | The Design, Synthesis And Preliminary Activity Assay In Vitro Of Trypsin-like Serine Inhibitor |
193. | Design, Synthesis And Activity Of α, β-Unsaturated Carbonyl Derivatives |
194. | Studies On The Design, Synthesis Of CB1 Receptor Antagonists |
195. | Design, Synthesis And Bioactivity Studies Of The Novel Ligustrazine Derivatives |
196. | Structure-Based Design, Synthesis And Screening Of The Xanthine Oxidase Inhibitors |
197. | Design, Synthesis And Physico-Chemical Property Activitees Of Derivatives Of Lincomycin |
198. | Design, Synthesis And Biological Activity Studies Of The Novel Stilbene Derivatives Containing Ligustrazinyl Group |
199. | Design, Synthesis And Biological Activity Of 3-O-Carbamate Macrolide Derivatives Against Resistant Bacteria |
200. | Design, Synthesis And Preliminary Activity Assay In Vitro Of L-Lysine Derivatives As APN Inhibitors |
|